Viatris (VTRS) Stock Price, Quote, News & History | Benzinga

Viatris Inc (VTRS) Stock Price, Quote, News & History

VTRSNASDAQ

Trade with Public

Trade with Public

$16.34

-0.55-3.26%

At close: Aug 28, 5:00 PM EST

$16.30

-0.037-0.23%

After Hours: Aug 28, 7:16 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$16.93

Close

$16.34

Volume / Avg.

6.22M / 9.82M

Day Range

$16.30 - $17.01

52 Wk Range

9.43 - 18.39

Market Cap

$18.73B

P/E Ratio

-

Dividend Yield

2.84%

Exchange

NASDAQ

RSI

44

Short Interest

3.23%

Days to Cover

2.96

Recent Viatris Inc. News

Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook

Viatris sells Tyrvaya to Harrow for up to $100 million, raises 2026 guidance after second-quarter earnings and revenue beat estimates.

Vandana Singh

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Investors turn to dividend-yielding stocks during market turbulence. Benzinga's Analyst Stock Ratings page provides latest analyst takes on top stocks, sorted by accuracy. Ratings for three high-yielding health care stocks: VTRS, MDT, GSK. VTRS to report Q2 results on Aug.6, MDT recalls certain catheter system, GSK reports positive trial results. Benzinga Pro's newsfeed provides real-time alerts.

Avi Kapoor

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Investors turn to dividend-yielding stocks in turbulent markets. Benzinga offers latest analyst ratings for high-yielding stocks, including accuracy rates.

Avi Kapoor

RFK Jr. Wants Fewer Americans On Antidepressants — Here's Why The Debate Is Exploding

U.S. officials discussed possible SSRI restrictions as RFK Jr. unveiled a broader push to reduce antidepressant use.

Vandana Singh

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

Investors turn to high-yielding dividend stocks in turbulent markets. Benzinga readers can check analyst ratings for top health care stocks. MDT, ABBV, VTRS are discussed.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

2.33B

Investing Cash Flow (TTM)

-84.30M

Financing Cash Flow (TTM)

-1.91B

Free Cash Flow (TTM)

1.81B

Capital Expenditure (TTM)

-518.60M

Net Change in Cash (TTM)

335.60M

Analyst Trends and Forecast

1

Mar

2

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$30.90B

PE Ratio (TTM)

-

PE Ratio (FWD)

6.74

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.34

PB Ratio (TTM)

1.36

Earnings Yield % (TTM)

-2.19%

Earnings Yield % (FWD)

14.83%

EV / EBITDA (TTM)

12.02

Price / EBITDA (TTM)

7.51

Price / Free Cash Flow (TTM)

10.87

Book Value / Share

$12.42

Company Debt

Total Debt

$13.35B

LT Debt

$11.61B

LT Debt Issuance (TTM)

$1.30B

LT Debt Repayment (TTM)

-$2.23B

Total Cash

$886.50M

Debt to Equity

0.96

Issuance of Debt (TTM)

-$922.30M

Repayment of Debt (TTM)

-$2.23B

Key Statistics

Open

$16.93

Close

$16.34

Volume / Avg.

6.22M / 9.82M

Day Range

$16.30 - $17.01

52 Wk Range

9.43 - 18.39

Market Cap

$18.73B

P/E Ratio

-

Dividend Yield

2.84%

Exchange

NASDAQ

RSI

44

Short Interest

3.23%

Days to Cover

2.96

About

Sector

Health Care

Industry

Pharmaceuticals

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining f...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Viatris (VTRS) stock?

A

You can purchase shares of Viatris (NASDAQ:VTRS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Viatris (VTRS) competitors?

A

Other companies in Viatris’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Viatris (VTRS) stock?

A

Viatris has a consensus price target of $14.33.

Q

What is the current price for Viatris (VTRS)?

A

The stock price for Viatris (NASDAQ: VTRS) is $16.303 last updated August 28, 2026 at 7:16 PM EDT.

Q

Does Viatris (VTRS) pay a dividend?

A

There are no upcoming dividends for Viatris.

Q

When is Viatris (NASDAQ:VTRS) reporting earnings?

A

Viatris does not have any upcoming earnings scheduled.

Q

Is Viatris (VTRS) going to split?

A

There is no upcoming split for Viatris.

Q

What sector and industry does Viatris (VTRS) operate in?

A

Viatris is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.